Δccr5 Genotype Is Associated with Mild Form of Nephropathia Epidemica by Kletenkov, Konstantin et al.
viruses
Article
∆ccr5 Genotype Is Associated with Mild Form of
Nephropathia Epidemica
Konstantin Kletenkov 1, Ekaterina Martynova 1, Yuriy Davidyuk 1 , Emmanuel Kabwe 1,
Anton Shamsutdinov 1, Ekaterina Garanina 1, Venera Shakirova 2, Ilsiyar Khaertynova 2 ,
Vladimir Anokhin 3 , Rachael Tarlinton 4 , Albert Rizvanov 1 , Svetlana Khaiboullina 1,5
and Sergey Morzunov 6,*
1 Openlab “Gene and Cell Technologies”, Institute of Fundamental Medicine and Biology Kazan Federal
University, Kazan 420008, Republic of Tatarstan, Russian
2 Department of Infectious Diseases, Kazan State Medical Academy, Kazan 420012,
the Republic of Tatarstan, Russian
3 Department of Pediatric Infectious Diseases, Kazan State Medical University, Kazan 420012,
Republic of Tatarstan, Russian
4 School of Veterinary Medicine and Science, University of Nottingham, Loughborough LE12 5RD, UK
5 Department of Microbiology and Immunology, University of Nevada, Reno, NV 89557, USA
6 Department of Pathology, University of Nevada, Reno, NV 89557, USA
* Correspondence: smorzunov@medicine.nevada.edu
Received: 24 May 2019; Accepted: 17 July 2019; Published: 23 July 2019


Abstract: Nephropathia Epidemica (NE), a mild form of hemorrhagic fever with renal syndrome
(HFRS) and linked to hantavirus infection, is endemic in the Republic of Tatarstan. Several genetic
markers of HFRS severity have been identified previously, including human leukocyte antigen (HLA)
complexes and nucleotide polymorphism in the tumor necrosis factor alpha (TNFα) gene. Still, our
understanding of the genetic markers of NE severity remains incomplete. The frequency of the C–C
chemokine receptor type 5 (CCR5) gene wild type and gene with 32-base-pair deletion (∆32CCR5)
genotypes in 98 NE samples and 592 controls was analyzed using PCR. Along with the serum levels of
94 analytes, a lack of differences in the CCR5 genotype distribution between NE cases and the general
population suggests that the CCR5 genotype does not affect susceptibility to hantavirus infection.
However, in NE cases, significant variation in the serum levels of the host matrix metalloproteases
between functional CCR5 homozygous and ∆32CCR5 heterozygous patients was detected. Also,
the oliguric phase was longer, while thrombocyte counts were lower in functional CCR5 homozygous
as compared to heterozygous NE cases. Our data, for the first time, presents the potential role of the
CCR5 receptor genotype in NE pathogenesis. Our data suggests that NE pathogenesis in functional
CCR5 homozygous and heterozygous NE patients differs, where homozygous cases may have more
disintegration of the extracellular matrix and potentially more severe disease.
Keywords: nephropathia epidemica; hemorrhagic fever with renal syndrome; cytokines; matrix
metalloprotease; CCR5; ∆32CCR5
1. Introduction
Nephropathia epidemica (NE), the mild form of hemorrhagic fever with renal syndrome (HFRS)
triggered by hantavirus infection, is endemic in the republic of Tatarstan [1]. Kidney failure is commonly
associated with the most severe form of NE [2]. The lack of virus replication in the damaged tissues
suggests that the disease pathogenesis is most likely the result of the host reaction to virus infection.
However, the molecular mechanisms of NE pathogenesis remain largely unknown.
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A mononuclear leukocyte infiltration is often found in the kidney tissue of NE cases [3]. The most
consistent finding is that these leukocytes include CD8+ T cells and monocytes, suggesting their role
in the disease pathogenesis. Mononuclear leukocyte migration is regulated by a group of chemokines
including chemokine (C–C motif) ligand 2 (CCL2), chemokine (C–C motif) ligand 3 (CCL3), chemokine
(C–C motif) ligand 5 (CCL5), and chemokine (C–C motif) ligand 10 (CXCL10) [4], all of which we have
found increased in the serum of NE cases [5].
Chemokine-directed leukocyte migration is regulated by expression of a unique set of receptors,
including CCR5 [6]. CCR5 is essential for guiding the migration of activated and effector T cells [7].
Hence, CCR5 gene polymorphism could affect the severity of virus infection [8,9].
Our data suggests that a CCL5-CCR5 interaction could be involved in the leukocyte migration and
tissue accumulation commonly found in NE and HFRS cases [10,11]. This assumption is confirmed by
the fact that leukocytes infiltrating NE tissue have a CD8+ and activated T cell phenotype, which is
the main target for CCL5-CCR5 driven chemotaxis [10,12]. Although leukocyte accumulation in NE
tissues is well-documented, the effect of the CCR5 genotype on the clinical presentation of NE remains
largely unknown.
This study reports that the frequency of functional wild type (wt) CCR5 homozygous, CCR5/CCR5
gene with 32-base-pair deletion (∆32CCR5) heterozygous, and ∆32CCR5 homozygous genotypes
is similar between the general population of the Republic of Tatarstan and NE cases, suggesting
that susceptibility to hantavirus infection is independent of CCR5 genotype. Serum levels of matrix
metalloproteases (MMPs) and IL9 in functional CCR5 homozygous NE patients were significantly
higher than that in heterozygous NE patients while IL32 levels were decreased (there were too few
∆32CCR5 patients to analyze). On the other hand, downregulated levels of Platelet Derives Growth
Factor BB (PDGFBB), Interferon gamma (IFNγ), IL32 and TNF-related apoptosis-inducing ligand
(TRAIL) were associated with severe form of NE. Upregulation of MMP2, creatinine, CSF2, CXCL12,
and CCL27 was linked to the mild NE form. Also, the duration of the oliguric phase of the clinical
disease was longer, while thrombocyte counts were lower in functional CCR5 homozygous as compared
to heterozygous NE (indicating more severe disease). Our data suggests that the functional CCR5
homozygous NE may have more pronounced disintegration of the extracellular matrix (ECM) and
increased leukocyte trans-endothelial migration as compared to heterozygous cases. Our data, for the
first time, presents the potential role of CCR5 receptor genotype in pathogenesis of NE.
2. Materials and Methods
2.1. Subjects
Serum samples from 98 subjects (80 male and 18 female) admitted to the Agafonov Republican
Clinical Hospital for Infectious Disease, Republic of Tatarstan between spring 2015 and fall 2016 were
used in the study. Diagnosis of NE was established based on clinical presentation and was serologically
confirmed by detection of anti-hantavirus IgG antibodies. Samples were collected following the
standard operating protocol for diagnosis of hantavirus infection. Briefly, blood samples were collected
into a vacutainer and allowed to coagulate at 37 ◦C for 30 min. The serum was separated (2000× g;
10 min) and stored at −80 ◦C. Serum from 27 controls (22 male and 5 female) were collected.
Additionally, cheek swabs from the 98 NE patients and 592 donors (423 male and 169 female)
were collected and used for DNA extraction.
2.2. Ethics Statement
The Ethics Committee of the Kazan Federal University approved this study, and informed consent
was obtained from each NE patient and controls according to the guidelines approved under this
protocol (article 20, Federal Law “Protection of Health Right of Citizens of Russian Federation” N323-FZ,
21 November 2011).
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2.3. Hantavirus ELISA
The Hantagnost diagnostic ELISA kit (Institute of Poliomyelitis and Viral Encephalitis, Moscow,
Russia) was used to determine the hantavirus-specific antibody titers.
2.4. DNA Extraction and PCR
DNA was extracted from blood (100 µL) and cheek swab samples using a DNA/RNA extraction
kit (Litekh, Moscow, Russia). The CCR5 genotype was determined by PCR using primers [13] spanning
over the exon 4 region of the CCR5 gene, which is known to be polymorphic. Amplification products
were separated by gel electrophoresis. Functional and 32 nt deletion (∆32CCR5) PCR products were
visually discriminated (Figure 1).
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coefficients higher than 0.5, the mean absolute correlation of each variable was calculated. Then, the 
variable with the largest mean absolute correlation was removed. 
Figure 1. PCR analysis of CCR5 genotype: Total DNA was extracted and used for PCR amplification.
Expected sizes for functional CCR5 are 225 bp and for ∆32CCR5 are 193 bp. wt/wt—functional CCR5
homozygous; wt/∆32—functional heterozygous; ∆32/∆32—non-functional ∆32CCR5 homozygous;
M—molecular weight marker.
2.5. Multiplex Analysis
Serum levels of 94 analytes was analyzed using Bio-Plex (Bio-Rad, Hercules, CA, USA) multiplex
magnetic bead-based antibody detection kits following manufacturer’s instructions. Multiplex kits
(Bio-Rad, Hercules, CA, USA), Bio Plex Pro Human Cytokine 21-plex, Bio Plex Human Cytokine
27-plex, Bio Plex Human Cytokine 37-plex, and Bio-Plex Human MMP Panel panels were used in the
study. Data collected was analyzed using with MasterPlex CT control software and MasterPlex QT
analysis software (MiraiBio, Alameda, CA, USA).
2.6. Statistical Analysis
Statistical analysis was conducted using R language for statistical computing [14], RStudio [15],
and package “t bleone” [16]. Illustrations were built with the “ggplot2” package 7 . Continuous
variables w re prese ted with their respectiv median (M), first (Q1), and third (Q3) quartiles.
C tegorical variables w re present d with proportions and percentages. Compar sons were c ri d
out using Mann–Whitn y U tests for continuous and Fisher’s exact t ts for c tegorical vari bl s.
The threshold used for statistical signifi a ce was p < 0.05.
Rel vance of seve ity-a sociated continuous variables was reported as common language effect
size (using pa kage “canprot” [18]), rank-biserial correl tion (the simple difference formula), s w ll as
pseudomedian and its nonparametric 95% confidence interval (CI). In case of cat g ical variables,
odds ratio (OR) and its 95% CI were c lculated. In order to retain only the most prognostically valuable
analytes, redundant features were removed using a pairwise spearman c rrelat on analysis with
packages “caret” nd “r shape2” [19–21]. If two variables had correlation coefficients higher th n 0.5,
the mean absolute correlation of each v iable was calculated. Then, the variable with t e largest mea
absolut correlation was removed.
Path ay analysis was done using the Pathway Studio MammalPlus (Elsevier, Amsterdam,
The Netherlands). Analytes which differ significantly between groups were used for enrichment
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analysis. Only pathways with p < 0.05 after correction for the multiple comparison were selected.
The Benjamini–Hochberg method was used to control the false discovery rate.
3. Results
3.1. CCR5 Genetics in NE Cases and Tatarstan Population
Distribution of functional type CCR5 gene and the gene with 32-base-pair deletion (∆32CCR5)
was analyzed in 592 donors representing the general population of Tatarstan. Using PCR, the genotype
was determined as functional CCR5 homozygous, heterozygous, or ∆32CCR5 homozygous. A total of
492 individuals (83.1%) was determined as having the functional CCR5 homozygous genotype, while
94 (15.9%) individuals were heterozygous and only 6 (1.0%) individuals were ∆32CCR5 homozygous.
In NE cases, the CCR5 genotype distribution was similar to that in the general population, where
80 patients (81.7%) had functional CCR5 homozygous genotype, 16 cases (16.3%) were heterozygous,
and 2 (2.0%) were ∆32CCR5 homozygous. Differences in CCR5 genotype distribution between the
general population and NE controls were not significant (Fisher’s exact test p = 0.516). Therefore, there
is no evidence for CCR5 genotype contributing to susceptibility to hantavirus infection.
3.2. Patient’s Clinical Characteristics
A total of 98 NE cases (80 males, 18 females) was recruited for this study. However, the low
number of ∆32CCR5 homozygous NE (total of 2) was not sufficient for statistical analysis; therefore,
they were excluded. Hence, 96 NE cases were selected for the study, which will be referred to
as homozygous (functional CCR5/functional CCR5) and heterozygous (functional CCR5/∆32CCR5).
Baseline characteristics were summarized in Table S1. The median age of homozygous and heterozygous
patients did not differ significantly (M = 37.00 years, Q1 = 29.00, Q3 = 51.00, n = 79 vs. M = 42.00 years,
Q1 = 33.00, Q3 = 49.50, n = 15, respectively; Mann–Whitney U test p = 0.522). Most of the patients were
male in both groups 64 (80.0%) males and 16 (20.0%) females for homozygous; 14 (87.5%) males and 2
(12.5%) females for heterozygous); there was no difference in the sex of patients between homozygous
and heterozygous patients (Fisher’s exact test p = 0.728).
The duration of oliguria and thrombocyte counts differed significantly between homozygous
and heterozygous NE cases. The oliguric phase was shorter in heterozygous when compared to
homozygous NE cases (M = 0.00 days, Q1 = 0.00, Q3 = 0.00, n = 6 vs. M = 2.00 days, Q1 = 0.00, Q3 = 3.00,
n = 49; Mann–Whitney U test p = 0.013, adjusted p = 0.106). This data suggests less impact on kidney
function in heterozygous patients as compared to those with homozygous genotype. Additionally,
the thrombocyte counts were significantly higher in heterozygous as compared to homozygous NE
cases (M = 157.00 × 109/L, Q1 = 86.00, Q3 = 241.00, n = 15 vs. M = 89.00 × 109/L, Q1 = 64.00, Q3 = 125.00,
n = 77; Mann–Whitney U test p = 0.018; adjusted p = 0.106). Also, the thrombocyte counts were
significantly lower in homozygous NE as compared to controls (M = 214.00 × 109/L, Q1 = 200.00,
Q3 = 217.00, n= 9 vs. M = 89.00× 109/L, Q1 = 64.00, Q3 = 125.00, n = 77; Mann–Whitney U test adjusted
p < 0.001). Other clinical parameters did not show significant differences between groups of patients.
Thrombocyte counts are used to determine the risk for bleeding in hantavirus patients [22]. Our data
suggests that heterozygous NE would have lower risk of developing hemorrhagic disturbances as
compared to the homozygous genotype. Interestingly, there were two fatal NE case documented in the
2016 NE outbreak in the Republic of Tatarstan. PCR analysis of DNA extracted from the postmortem
collected tissue revealed the homozygous functional CCR5 genotype in both patients. Although
these are two cases and more studies are required, it appears that the homozygous functional CCR5
genotype is characterized in NE patients by more impact on kidney function and a higher chance of
developing hemorrhages.
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3.3. Assessment of Serum Analytes in NE Cases and Controls
A total of 94 analytes was measured including cytokines, chemokines, matrix metalloproteinases
(MMPs), and soluble receptors in 80 homozygous NE cases, 16 heterozygous NE cases and 27 controls
(median age 36.8 (Q1 = 23.5, Q3 = 49.3) years old). Eighty NE samples (median age 37.50 (range: 29.75,
51.50) years old) and twenty-seven controls (median age 36.8 (23.5, 49.3) years old).
The control CCR5 genotype was analyzed before conducting this analysis to make sure that the
genotype composition of the control represents that of the general population and resembles that of NE.
Functional homozygous CCR5 was 88.9%, while heterozygous CCR5 was 11.1% in the controls. This
distribution of CCR5 genotype frequency in controls closely resembles that in the general population
(83.1% and 15.9%, respectively) and in NE patients (81.7% and 16.3%, respectively).
The levels of 50 analytes were found to be differently expressed in homozygous NE cases as
compared to control (Figure 2; Table S2).
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Figure 2. Analysis of functio al CCR5 homo ous seru multiplex data: Serum (50 µL) was used
to detect serum levels of 94 analytes. All analytes were divided into TNF&Receptors, growth factors,
IFN-related, IL-related, other cytokines, chemokine-related, and MMPs, and their levels were compared
using the Mann–Whitney U test. The Benjamini–Hochberg method was used to control the false
discovery rate, and only analytes with p < 0.05 were selected. For every analyte, the ratio of median
level in functional CCR5 homozygous patients to that in control was calculated. Then, binary logarithm
of these values was used for sorting of analytes and generation of the “lollypop” diagram with the
“ggplot2” package.
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However, when adjusted p-values were calculated, the number of affected analytes was reduced
to forty-six. These analytes included chemokines, growth factors, interferons, interleukins/receptor,
MMPs, other cytokines, and tumor necrosis factors/receptor.
In the heterozygous NE cases, a lesser number of serum analytes (32 analytes) was found affected
as compared to controls (Figure 3; Table S3). After calculation of adjusted p-values, the level of 20
serum analytes remained significantly different from that in controls. These analytes included the
following categories: chemokines, growth factors, interferons, interleukins, and MMPs. Cytokines and
tumor necrosis factors/receptor were excluded in the heterozygous group when adjusted p-values were
calculated. Also, the greater number of analytes was in the growth factor, IFN, IL, and MMP categories
in homozygous as compared to heterozygous NE. Several cytokines such as sCD163, sIL6RA, PTX3,
SPP1, CHI3L1, and thymic stromal lymphopoietin were affected exclusively in homozygous NE. These
cytokines are involved in activation of inflammation, leukocyte migration, and differentiation [23,24].
Therefore, it could be suggested that homozygous NE will be characterized with more extensive
inflammation, leukocyte migration, and differentiation as compared to the heterozygous one.
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Figure 3. Analysis of functional CCR5/∆32CCR5 heterozygous serum multiplex data: Serum (50 µL)
was used to detect serum levels of 94 analytes. All analytes were divided into TNF&Rs, growth factors,
IFN-related, IL-related, other cytokines, chemokine-related, and MMPs, and their levels were compared
using the Mann–Whitney U test. The Benjamini–Hochberg method was used to control the false
discovery rate, and only analytes with p < 0.05 were selected. For every analyte, the ratio of median
level in functional CCR5/∆32CCR5 heterozygous patients to that in control was calculated. Then, binary
logarithm of these values was used for sorting of analytes and generation of the “lollypop” diagram
with the “ggplot2” package.
When 94 analytes were compared between homozygous and heterozygous NE, serum levels of
nine molecules (MMP2, MMP3, MMP8, MMP9, MMP10, MMP12, MMP13, IL9, and IL32) differed
significantly (Figure 4; Table S4). Levels of IL9 were higher (p = 0.011) while levels of IL32 were lower
(p = 0.014) in homozygous NE as compared to heterozygous cases (Figure 4; Table S4). Interestingly,
differences in serum levels of MMP2, MMP3, MMP8, MMP9, MMP10, MMP12, and MMP13 remained
significant after adjustment for multiple comparisons. MMP serum levels were upregulated in
homozygous cases as compared to that in heterozygous NE (Figure 4), suggesting that the matrix
remodeling is more pronounced in homozygous NE.
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Figure 4. Analytes differed significantly between functional CCR5 homozygous and functional
CCR5/∆32CCR5 heterozygous NE cases. The Mann–Whitney U test was used to compare analyte
levels between functional CCR5 homozygous and functional CCR5/∆32CCR5 heterozygous NE cases.
Analytes with p < 0.05 were used to generate logarithmic scaled radar plot. The Benjamini–Hochberg
method was used to control the false discovery rate. Asterisk marks those analytes differences
that remained significant after adjustment for multiple comparisons. Solid line—functional CCR5
homozygous patients; dotted line—functional CCR5/∆32CCR5 heterozygous patients.
3.4. Pathway Analysis in Functional CCR5 Homozygous and Heterozygous NE Cases
Only analytes which differ significantly between homozygous and heterozygous NE (MMP2, 3,
8, 9, 10, 12, and 13; IL9 and IL32) were included into the pathway analysis. Several pathways were
identified as activated in NE cases, including inflammation and tissue damage (see Figure 5 for a
typical pathway identified) and suggesting that extracellular matrix degradation and remodeling
plays a sig ificant role in functional CCR5 homozygous NE pathogenesis. All these pathways have
MMP activation in common, suggesting that extracellular matrix degradation and remodeling plays a
significant role in functional CCR5 homozygous NE path genesis.
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Figure 5. Pathway analysis of serum analytes in functional CCR5 homozygous and functional
CCR5/∆32CCR5 heterozygous NE—Interstitial Fibroblasts in Pyelonephritis. Pathway analysis was
done using the Pathway Studio MammalPlus (Elsevier) tool. Analytes which differ significantly
between groups were used for enrichment analysis. Only pathways with p < 0.05 after correction for
the multiple comparisons were selected. Blue color highlights analytes which were significantly lower
in functional CCR5/∆32CCR5 heterozygous NE.
3.5. Prognostic Value of CCR5 Genotype, PDGFBB, CCL27, and CXCL12
Duration of oliguria two days or longer and platelet count less than 150 × 109/L were selected as
criterion to define NE severity. Using these criterion, 31 patients had severe while 43 patients had mild
forms of NE. Interestingly, 12 out of 43 mild NE were heterozygous, while only 1 out of 31 severe NE
cases was heterozygous. These data support the association between homozygous CCR5 genotype and
the severe form of NE.
Next, these groups were compared to identify predictors of the disease severity. As potential
predictors of the disease severity, 14 analytes were selected (Table S5) in addition to CCR5 (p = 0.006,
OR = 11.32, 95% CI: 1.50–511.31). These analytes include MMPs, cytokines, chemokines, and creatinine,
which were shown to be involved in pathogenesis of hantavirus infection [25–27].
After exclusion of the redundant features (Table S6), creatinine, MMP2, Tumor Necrosis Factor
Ligand Superfamily Member 10 (TNFSF10), Colony Stimulating Factor 2 (CSF2), PDGFBB, IFNγ,
IL32, CCL27, and CXCL12 were retained. When a random patient with severe NE was compared to
a random patient with mild NE, the severe NE had higher serum levels of MMP2, creatinine, CSF2,
CXCL12, and CCL27 than the mild form in 63.9%, 64.4%, 66.8%, 71.0%, and 71.0%, respectively, of such
pairs. In contrast, higher levels of IL32, IFNγ, PDGFBB, and TNFSF10 were detected in only 24.6%,
28.5%, 31.7%, and 35.9% severe NE, respectively, while the mild form of the disease had higher rates of
these cytokines upregulated (75.4%, 71.5%, 68.3%, and 64.1%, respectively) (Figure S1).
In line with that, MMP2, creatinine, CSF2, CXCL12, and CCL27 showed positive rank-biserial
correlation with the severe disease, supporting the role of these cytokines in pathogenesis of this form
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of NE. There was negative rank-biserial correlation for TNFSF10, PDGFBB, IFNγ, and IL32, indicating
that these cytokines could act to ameliorate severe symptoms of the disease (Figure 6).
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Figure 6. Rank-biserial correlation (the simple difference formula) analysis to assess the relevance of the
severity-associated analytes: In order to retain only the most prognosis valuable analytes, redundant
features were excluded using pairwise spearman correlation analysis with packages “caret” and
“reshape2”. If two variables had absolute values of correlation coefficients higher than 0.5, the mean
absolute correlation of each variable was calculated (only correlation coefficients significantly different
from zero were considered). The variable with the largest mean absolute correlation was removed.
In absolute terms, pseudomedians for comparison between mild and severe NE analyte levels
were estimated as −113.19, −28, −3.39, −19.38, and −18.91 pg/mL for MMP2, creatinine, CSF2, CXCL12,
and CCL27, correspondingly. For IL32, IFNγ, PDGFBB, and TNF-related apoptosis-i ducing ligand
(TRAI ) levels pseudomedian were 16.66, 33.74, 233.29, and 11.60 pg/mL, respectively (Figure S2).
After considerin adjusted p-value , we c nclude that PDGFBB, IFNγ, CCL27, and CXCL12 in
addition to the CCR5 genotype could be utilized as predictors of the severe form of NE.
4. Discussion
The key finding of our study is that the CCR5 genotype affects the duration of the oliguric phase,
thrombocyte counts, and serum MMP levels in NE cases. The shorter oliguric phase and higher
thrombocyte counts found in heterozygous as compared to homozygous NE suggests amelioration of
clinical symptoms in heterozygous NE patients and, as a result, a milder form of the disease. This is
the first study where a genetic marker associated with the regulation of leukocyte trans-endothelial
migration has been shown to affect the duration of the oliguric phase and thrombocyte counts, which are
often used to determine the severity of the NE. The duration of the oliguric phase reflects the degree
of kidney damage [28]. The low thrombocyte counts are an early sign of hemorrhagic disturbances,
where the drop of thrombocyte counts below 50 cell/µL this indicates severe bleeding [29]. We have
shown that the thrombocyte counts were higher in heterozygous NE, suggesting a lower likelihood of
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hemorrhagic complications. Our data suggests that NE patients with a heterozygous genotype will
have a milder form of the disease and a lower likelihood of complications.
The cytokine storm hypothesis has been suggested to explain interrupted integrity of the
endothelial barrier and leukocyte migration in HFRS. One of the most consistent findings in hantavirus
cases is a high number of cytokine producing mononuclear leukocytes in the tissues [27]. The leukocyte
migration is highly regulated process, involving CHI3L1, tymic stromal lymphopoietin, and sCD163.
Several of these molecules are expressed by macrophages [23,24,30]. CCR5 is one of the main receptors
involved in recruiting activated Th1 cells [7,31]. Also, CCR5 plays a crucial role in recruitment of
memory CD8+ T cells into the tissue [32]. Interestingly, the phenotype of mononuclear leukocytes
infiltrating tissues in hantavirus-infected patients closely resembles those expressing the CCR5
receptor [3,11]. Therefore, we suggest that expression of functional CCR5 receptor is essential for
leukocyte trans-endothelial migration in NE.
The most striking observation was that serum MMP levels were significantly higher in homozygous
as compared to heterozygous NE. MMPs are involved in breaking down the extracellular matrix
(ECM) [33] and in releasing matrix-bound growth factors [34], which are essential for leukocyte
migration. Th1 lymphocytes producing MMP2 and MMP9 have higher migratory capacities as
compared to Th2 lymphocytes [35]. Also, homozygous NE patients had increased serum levels
of MMP3 and MMP10, targeting fibronectin and laminin [36,37], as compared to heretozygous NE
patients. Therefore, we suggest that MMP-induced ECM remodeling and leukocyte migration will be
more evident in homozygous as compared to heterozygous NE patients.
Serum cytokine analysis revealed that heterozygous NE patients were characterized by less
activation of the IL17 pathway as compared to homozygous cases. Interestingly, IL17 stimulates
production of MMP3, 9, and 13 in monocytes and macrophages [38], while Th17 lymphocytes can
produce MMP3 [39]. Coincidently, the levels of MMP3, 9, and 13 were higher in homozygous as
compared to heterozygous NE. Therefore, we suggest that, in homozygous NE, tissue infiltrating
leukocytes could contain Th17 populations. These leukocytes could locally produce cytokines
stimulating and attracting neutrophils, thereby enhancing inflammation.
An analysis of the PDGFBB, IFNγ, CCL27, CXCL12, and CCR5 for prognostic value for diagnosis
of severe NE revealed the predictive value of CCL27. We have demonstrated that increased CCL27
and being homozygous for the functional CCR5 genotype are characteristic for severe NE. CCL27 is a
chemoattractant for antigen-specific T lymphocytes [40]. Therefore, we suggest that antigen-specific T
lymphocytes migrate more effectively across the endothelium in severe as compared to mild forms of NE.
5. Conclusions
In conclusion, our data suggest that the CCR5 genotype could play a role in the pathogenesis of
NE. Although the CCR5 genotype does not contribute to the susceptibility to hantavirus infection,
those patients homozygous for functional CCR5 were characterized by a longer oliguric phase and
lower thrombocyte counts when compared to heterozygous NE cases. Also, significant differences in
serum levels of MMPs in homozygous and heterozygous NE cases were detected. Our data suggests
differences in NE pathogenesis where homozygous cases have more pronounced disintegration of
the ECM and increased activated Th1 lymphocyte migration across the endothelial barrier. Pathway
analysis revealed activation of the Th17 pathway in homozygous NE cases. Our data, for the first time,
presents the role of the CCR5 receptor genotype in NE pathogenesis.
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